New award for influenza vaccine for the 2024-2025 flu season, with glaxosmithkline LLC. The period of performance is 03/15/2024 - 03/14/2025
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79724D0005
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 90 $4,600,428 obligated
Award facts
- Opportunity
-
- 6505--Influenza Vaccine (2024-2025 influenza season) Pre-Solicitation · 36E79723R0027 · Posted Jul 26, 2023
- Combined order value
-
- $4,600,690 Current, with exercised options
- $4,622,530 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 29% used
- $15,647,512.50
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This federal contract IDV award to Glaxosmithkline, LLC from the Department of Veterans Affairs (VA) National Acquisition Center procures influenza vaccines for use by the VA, Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center. The contract has a total estimated annual usage of 306,829 vaccine doses across various product types including 10-dose vials, pre-filled pediatric syringes, and pre-filled syringes for adults 36 months and older, including those specifically designed for the 65+ population.
The contract is not set aside for any special business category. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, will deliver the vaccines across the U.S., Philippines, and Puerto Rico under a firm fixed price arrangement with a period of performance from August 2024 through October 2024. This award supports federal vaccination and disease prevention efforts for veterans, inmates, Native Americans, and active duty personnel and their families. Multiple delivery order contracts issued against this IDV provide additional details on product types, quantities, and pricing for specific government facilities.
Task orders
Show 40 more
Latest 50 of 90 listed here. See the rest on GovTribe.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724D0005?
36E79724D0005 was awarded to Glaxosmithkline, LLC by National Acquisition Center (Headquarters) on March 15, 2024.
How much is contract 36E79724D0005 worth?
Orders under 36E79724D0005 have obligated $4,600,428. Their combined current value, with exercised options, is $4,600,690. Their combined potential value, with all options, is $4,622,530. 36E79724D0005's own ceiling is $15,647,513.
How many orders have been placed under contract 36E79724D0005?
90 orders have been placed under 36E79724D0005, the latest on April 10, 2025.
Who can order from contract 36E79724D0005?
36E79724D0005 is a single award indefinite delivery contract.
Was contract 36E79724D0005 competed?
The extent of competition for 36E79724D0005 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV